Application of High-Efficiency Cell Expansion and High-Throughput Drug Sensitivity Screening for Leukemia Treatment

Table 2

Complete remission analysis of ALL.

Characteristics	Total CR rate (%)	CR rate/non-HEHDS guided (%)	CR rate/HEHDS guided (%)	values^1
	19/27 (70.37)	9/16 (56.25)	10/11 (90.91)	0.062
New diagnosed	9/11 (81.82)	2/4 (50)	7/7 (100)	0.109
Relapsed	10/16 (62.5)	7/12 (58.3)	3/4 (75)	0.511
value^2	0.261	0.608	0.364

¹Non-HEHDS-guided CR rate vs. HEHDS-guided CR rate. ²The CR rate of new diagnosed vs. the CR rate of relapsed.